Hypertensive disease
|
0.100 |
Biomarker
|
group |
BEFREE |
Hypertension was defined as SBP at least 130 mmHg or DBP at least 80 mmHg, taking antihypertensive medicine or self-report.
|
31356404 |
2019 |
Aortic Stiffness
|
0.020 |
Biomarker
|
phenotype |
BEFREE |
Aortic stiffness and central SBP are independently associated with orthostatic SBP fall in CKD patients.
|
31598911 |
2019 |
Polycystic Ovary Syndrome
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Sex hormone-binding globulin levels were lower in women with PCOS and in groups 1 and 3 than those in group N (P < 0.002, P < 0.02, and P < 0.002, respectively) independently of the body mass index.
|
10566641 |
1999 |
Klinefelter Syndrome
|
0.020 |
Biomarker
|
disease |
BEFREE |
ABP profiles were significantly smaller in men with Klinefelter's syndrome who were negative for spermatozoa compared with men who were positive.
|
11925377 |
2002 |
Klinefelter's syndrome - male with more than two X chromosomes
|
0.010 |
Biomarker
|
disease |
BEFREE |
ABP profiles were significantly smaller in men with Klinefelter's syndrome who were negative for spermatozoa compared with men who were positive.
|
11925377 |
2002 |
Familial (FPAH)
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Sex hormone-binding globulin polymorphisms in familial and sporadic breast cancer.
|
12151349 |
2002 |
Sporadic Breast Carcinoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Sex hormone-binding globulin polymorphisms in familial and sporadic breast cancer.
|
12151349 |
2002 |
Gestational Diabetes
|
0.100 |
AlteredExpression
|
phenotype |
LHGDN |
Sex hormone binding globulin offers a potential early marker to target women who are at risk for gestational diabetes mellitus.
|
12861158 |
2003 |
Malignant neoplasm of breast
|
0.100 |
Biomarker
|
disease |
BEFREE |
Sex hormone-binding globulin action in estrogen breast cancer cells is strongly associated to cell growth and estrogen-sensitivity.
|
17447168 |
2007 |
Breast Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Sex hormone-binding globulin action in estrogen breast cancer cells is strongly associated to cell growth and estrogen-sensitivity.
|
17447168 |
2007 |
Neuroblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
SHBG internalization was specific as it did not occur in either the human neuroblastoma cell line SK-N-SH or the glioma cell line C6.
|
17684316 |
2007 |
Central neuroblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
SHBG internalization was specific as it did not occur in either the human neuroblastoma cell line SK-N-SH or the glioma cell line C6.
|
17684316 |
2007 |
Childhood Neuroblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
SHBG internalization was specific as it did not occur in either the human neuroblastoma cell line SK-N-SH or the glioma cell line C6.
|
17684316 |
2007 |
Glioma
|
0.010 |
Biomarker
|
disease |
BEFREE |
SHBG internalization was specific as it did not occur in either the human neuroblastoma cell line SK-N-SH or the glioma cell line C6.
|
17684316 |
2007 |
Depressive disorder
|
0.050 |
Biomarker
|
disease |
BEFREE |
SHBG alone explained 8% of variance of the CES-D depression score.
|
23602133 |
2013 |
Mental Depression
|
0.040 |
Biomarker
|
disease |
BEFREE |
SHBG alone explained 8% of variance of the CES-D depression score.
|
23602133 |
2013 |
Depressed mood
|
0.040 |
Biomarker
|
phenotype |
BEFREE |
SHBG alone explained 8% of variance of the CES-D depression score.
|
23602133 |
2013 |
Presenile dementia
|
0.020 |
Biomarker
|
disease |
BEFREE |
Sex hormone-binding globulin (SHBG), a major controlling factor in the proportion of bioavailable versus bound testosterone and estrogen, has been proposed to contribute to links between hormones and dementia, but has not yet been investigated fully in a prospective biomarker trial.
|
27767986 |
2017 |
Dementia
|
0.020 |
Biomarker
|
disease |
BEFREE |
Sex hormone-binding globulin (SHBG), a major controlling factor in the proportion of bioavailable versus bound testosterone and estrogen, has been proposed to contribute to links between hormones and dementia, but has not yet been investigated fully in a prospective biomarker trial.
|
27767986 |
2017 |
Osteoporosis, Age-Related
|
0.010 |
Biomarker
|
disease |
BEFREE |
SHBG may play a role in regulating age-related bone loss in men after middle-age.
|
27873076 |
2017 |
Diabetes Mellitus, Non-Insulin-Dependent
|
0.400 |
Biomarker
|
disease |
BEFREE |
SHBG and TE are independent risk factors for the development of T2D in women.
|
28223343 |
2017 |
Metabolic Diseases
|
0.050 |
Biomarker
|
group |
BEFREE |
Sex Hormone-Binding Globulin Reduction in Metabolic Disorders May Play a Role in NAFLD Development.
|
28359088 |
2017 |
Impaired glucose tolerance
|
0.030 |
Biomarker
|
phenotype |
BEFREE |
SHBG decreased stepwise with worsening categories of glucose intolerance in females whereas FAI decreased stepwise with worsening categories in males only.
|
28950181 |
2017 |
Diabetes
|
0.100 |
Biomarker
|
disease |
BEFREE |
SBP ≥140 mmHg (OR = 0.78; 95% CI: 0.65-0.95), DBP ≥90 mmHg (OR = 0.71; 95% CI: 0.58-0.88), and a positive family history of diabetes (OR = 0.77; 95% CI: 0.66-0.9) were found as protective factors against zero or five EDP in blood pressure recording the male gender (OR = 1.18; 95% CI: 1.04-1.35) was found to be its independent risk factor.
|
29137464 |
2017 |
Diabetes Mellitus
|
0.100 |
Biomarker
|
group |
BEFREE |
SBP ≥140 mmHg (OR = 0.78; 95% CI: 0.65-0.95), DBP ≥90 mmHg (OR = 0.71; 95% CI: 0.58-0.88), and a positive family history of diabetes (OR = 0.77; 95% CI: 0.66-0.9) were found as protective factors against zero or five EDP in blood pressure recording the male gender (OR = 1.18; 95% CI: 1.04-1.35) was found to be its independent risk factor.
|
29137464 |
2017 |